Raymond James Financial Inc. Makes New Investment in Charles River Laboratories International, Inc. (NYSE:CRL)
Raymond James Financial Inc. acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 231,720 shares of the medical research company’s stock, valued at approximately $42,776,000. A number of other large investors have also added to or reduced their stakes in […]
Raymond James Financial Inc. acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 231,720 shares of the medical research company’s stock, valued at approximately $42,776,000. A number of other large investors have also added to or reduced their stakes in […]
